News

Irish expert hails Swift® device after 950 treatments conducted

9 April 2024
/ News

A leading podiatrist and business owner who has completed nearly 1000 treatments using our revolutionary Swift® device has hailed its potential as the future of treating painful skin lesions.

Emblation CEO wins prestigious life sciences honour

18 March 2024
/ News

Our co-founder Gary Beale, has won a major life sciences award recognising outstanding business leadership. With a career spanning more than 25 years, he has led the company through a series of impressive milestones.

Leading podiatrist hails Swift as most effective treatment

11 December 2023
/ News

A new research study has shown that four out of every five patients suffering from a common skin condition are likely to see successful outcomes after using our microwave technology.

Council leaders welcome Emblation at new Stirling office

8 September 2023
/ News

Emblation has moved into its stunning new £4m office in Stirling, ushering in the start of a new era. We have invested heavily in our new HQ Emblation House – which boasts a sauna, gym, chillout area and a 90-person auditorium.

Major Singapore deal sets out route for global expansion

24 July 2023
/ News

We at Emblation have partnered with one of the top aesthetic equipment distributors in Singapore to expand the global reach of our innovative microwave device.

Emblation launches major $2m US clinical trial

15 June 2023
/ News

The Emblation team is undertaking a rigorous clinical trial which could transform the fortunes of our microwave treatments in the US.

Swift® could hold key to cervical cancer treatment

7 May 2023
/ News

Technology pioneered by our Emblation team has featured in promising new research which could deliver less painful and more effective treatment for cervical cancer patients.

Across a range of medical areas, the potential is huge. We are - and will remain - at the forefront of pioneering.